Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Enhanced protection conferred by mucosal BCG vaccination associates with presence of antigen-specific lung tissue-resident PD-1+ KLRG1- CD4+ T cells.

Bull NC, Stylianou E, Kaveh DA, Pinpathomrat N, Pasricha J, Harrington-Kandt R, Garcia-Pelayo MC, Hogarth PJ, McShane H.

Mucosal Immunol. 2019 Mar;12(2):555-564. doi: 10.1038/s41385-018-0109-1. Epub 2018 Nov 16.

2.

Induction and maintenance of a phenotypically heterogeneous lung tissue-resident CD4+ T cell population following BCG immunisation.

Bull NC, Kaveh DA, Garcia-Pelayo MC, Stylianou E, McShane H, Hogarth PJ.

Vaccine. 2018 Sep 5;36(37):5625-5635. doi: 10.1016/j.vaccine.2018.07.035. Epub 2018 Aug 7.

3.

Parenteral adenoviral boost enhances BCG induced protection, but not long term survival in a murine model of bovine TB.

Kaveh DA, Garcia-Pelayo MC, Webb PR, Wooff EE, Bachy VS, Hogarth PJ.

Vaccine. 2016 Jul 25;34(34):4003-11. doi: 10.1016/j.vaccine.2016.06.032. Epub 2016 Jun 16.

4.

Boosting BCG with inert spores improves immunogenicity and induces specific IL-17 responses in a murine model of bovine tuberculosis.

Garcia-Pelayo MC, Kaveh DA, Sibly L, Webb PR, Bull NC, Cutting SM, Hogarth PJ.

Tuberculosis (Edinb). 2016 May;98:97-103. doi: 10.1016/j.tube.2016.03.004. Epub 2016 Mar 30.

5.

BALB/c mice display more enhanced BCG vaccine induced Th1 and Th17 response than C57BL/6 mice but have equivalent protection.

Garcia-Pelayo MC, Bachy VS, Kaveh DA, Hogarth PJ.

Tuberculosis (Edinb). 2015 Jan;95(1):48-53. doi: 10.1016/j.tube.2014.10.012. Epub 2014 Nov 11.

6.

Persistent BCG bacilli perpetuate CD4 T effector memory and optimal protection against tuberculosis.

Kaveh DA, Garcia-Pelayo MC, Hogarth PJ.

Vaccine. 2014 Dec 5;32(51):6911-6918. doi: 10.1016/j.vaccine.2014.10.041. Epub 2014 Nov 4.

7.

Development of an unbiased antigen-mining approach to identify novel vaccine antigens and diagnostic reagents for bovine tuberculosis.

Jones GJ, Khatri BL, Garcia-Pelayo MC, Kaveh DA, Bachy VS, Hogarth PJ, Wooff E, Golby P, Vordermeier HM.

Clin Vaccine Immunol. 2013 Nov;20(11):1675-82. doi: 10.1128/CVI.00416-13. Epub 2013 Aug 28.

8.

European 2--a clonal complex of Mycobacterium bovis dominant in the Iberian Peninsula.

Rodriguez-Campos S, Schürch AC, Dale J, Lohan AJ, Cunha MV, Botelho A, De Cruz K, Boschiroli ML, Boniotti MB, Pacciarini M, Garcia-Pelayo MC, Romero B, de Juan L, Domínguez L, Gordon SV, van Soolingen D, Loftus B, Berg S, Hewinson RG, Aranaz A, Smith NH.

Infect Genet Evol. 2012 Jun;12(4):866-72. doi: 10.1016/j.meegid.2011.09.004. Epub 2011 Sep 14.

PMID:
21945286
9.

African 2, a clonal complex of Mycobacterium bovis epidemiologically important in East Africa.

Berg S, Garcia-Pelayo MC, Müller B, Hailu E, Asiimwe B, Kremer K, Dale J, Boniotti MB, Rodriguez S, Hilty M, Rigouts L, Firdessa R, Machado A, Mucavele C, Ngandolo BN, Bruchfeld J, Boschiroli L, Müller A, Sahraoui N, Pacciarini M, Cadmus S, Joloba M, van Soolingen D, Michel AL, Djønne B, Aranaz A, Zinsstag J, van Helden P, Portaels F, Kazwala R, Källenius G, Hewinson RG, Aseffa A, Gordon SV, Smith NH.

J Bacteriol. 2011 Feb;193(3):670-8. doi: 10.1128/JB.00750-10. Epub 2010 Nov 19. Erratum in: J Bacteriol. 2012 Mar;194(6):1641.

10.

Characterization of the transcriptional regulator Rv3124 of Mycobacterium tuberculosis identifies it as a positive regulator of molybdopterin biosynthesis and defines the functional consequences of a non-synonymous SNP in the Mycobacterium bovis BCG orthologue.

Mendoza Lopez P, Golby P, Wooff E, Garcia JN, Garcia Pelayo MC, Conlon K, Gema Camacho A, Hewinson RG, Polaina J, Suárez García A, Gordon SV.

Microbiology. 2010 Jul;156(Pt 7):2112-2123. doi: 10.1099/mic.0.037200-0. Epub 2010 Apr 8.

11.

A comprehensive survey of single nucleotide polymorphisms (SNPs) across Mycobacterium bovis strains and M. bovis BCG vaccine strains refines the genealogy and defines a minimal set of SNPs that separate virulent M. bovis strains and M. bovis BCG strains.

Garcia Pelayo MC, Uplekar S, Keniry A, Mendoza Lopez P, Garnier T, Nunez Garcia J, Boschiroli L, Zhou X, Parkhill J, Smith N, Hewinson RG, Cole ST, Gordon SV.

Infect Immun. 2009 May;77(5):2230-8. doi: 10.1128/IAI.01099-08. Epub 2009 Mar 16.

12.

African 1, an epidemiologically important clonal complex of Mycobacterium bovis dominant in Mali, Nigeria, Cameroon, and Chad.

Müller B, Hilty M, Berg S, Garcia-Pelayo MC, Dale J, Boschiroli ML, Cadmus S, Ngandolo BN, Godreuil S, Diguimbaye-Djaibé C, Kazwala R, Bonfoh B, Njanpop-Lafourcade BM, Sahraoui N, Guetarni D, Aseffa A, Mekonnen MH, Razanamparany VR, Ramarokoto H, Djønne B, Oloya J, Machado A, Mucavele C, Skjerve E, Portaels F, Rigouts L, Michel A, Müller A, Källenius G, van Helden PD, Hewinson RG, Zinsstag J, Gordon SV, Smith NH.

J Bacteriol. 2009 Mar;191(6):1951-60. doi: 10.1128/JB.01590-08. Epub 2009 Jan 9.

13.

Gene expression profiling and antigen mining of the tuberculin production strain Mycobacterium bovis AN5.

Garcia Pelayo MC, Garcia JN, Golby P, Pirson C, Ewer K, Vordermeier M, Hewinson RG, Gordon SV.

Vet Microbiol. 2009 Jan 13;133(3):272-7. doi: 10.1016/j.vetmic.2008.07.004. Epub 2008 Jul 25.

PMID:
18760551
14.

Identification of genetic markers for Mycobacterium pinnipedii through genome analysis.

Bigi F, Garcia-Pelayo MC, Nuñez-García J, Peralta A, Caimi KC, Golby P, Hinds J, Cataldi A, Gordon SV, Romano MI.

FEMS Microbiol Lett. 2005 Jul 15;248(2):147-52.

15.

Differential translational effects of myristic acid and eicosapentaenoic acid on 3-hydroxy-3-methylglutaryl-CoA reductase from Reuber H35 hepatoma cells.

García-Pelayo MC, García-Peregrín E, Martínez-Cayuela M.

Exp Biol Med (Maywood). 2004 Sep;229(8):781-6.

PMID:
15337832
16.

Microarray analysis of Mycobacterium microti reveals deletion of genes encoding PE-PPE proteins and ESAT-6 family antigens.

Garcia-Pelayo MC, Caimi KC, Inwald JK, Hinds J, Bigi F, Romano MI, van Soolingen D, Hewinson RG, Cataldi A, Gordon SV.

Tuberculosis (Edinb). 2004;84(3-4):159-66.

PMID:
15207485
17.

Modification of phospholipids fatty acid composition in reuber H35 hepatoma cells: effect on HMG-CoA reductase activity.

García-Pelayo MC, García-Peregrín E, Martínez-Cayuela M.

J Cell Biochem. 2003 Oct 15;90(3):586-91.

PMID:
14523992
18.

An improved assay of 3-hydroxy-3-methylglutaryl-CoA reductase activity in Reuber H35 hepatoma cells without microsomes isolation.

García-Pelayo MC, García-Peregrín E, Martínez-Cayuela M.

Analyst. 2000 Sep;125(9):1583-5.

PMID:
11064938
19.

Metabolism of palmitic and docosahexaenoic acids in Reuber H35 hepatoma cells.

Martínez-Cayuela M, García-Pelayo MC, Linares A, García-Peregrín E.

J Biochem. 2000 Oct;128(4):545-51.

Supplemental Content

Loading ...
Support Center